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Syncope is very common, with the overall incidence for first syncope being 6.2 
per 1000 patient years, increasing to 20 in females aged over 80 years [1].   
Vasovagal syncope (VVS) is by far the commonest cause, explaining over 20% of 
cases, with an underlying cardiac cause in 10% of cases and up to 37% of cases 
remaining unexplained [1].  
 
The importance of syncope cannot be understated.  It can have a negative impact 
upon education, physical activity and leisure, but can also result in loss of 
employment, driving restrictions, social isolation, falls and significant injury.  
Vasovagal syncope aside, cardiac and unexplained syncope are also associated 
with an increased mortality, necessitating accurate diagnosis [1]. 
 
The increase in morbidity and mortality is one of the driving forces behind the 
development of international guidelines and the creation of specialist syncope 
clinics.  When the European Society of Cardiology Practice Guideline is applied in 
a specialist syncope setting the rate of undiagnosed syncope decreases from 37% 
to 10% [2, 3].  Moreover, specialist syncope clinics reduce hospital readmission, 
reduce inappropriate use of investigations and reduce healthcare costs [4]. At 
the heart of these specialist clinics is the tilt-able. 
 
Tilt-table Testing 
Tilt table testing has been used as an adjunct in the diagnosis of vasovagal 
syncope since 1986 [5]. The test has been used with varying tilt angles and 
durations, and with various degrees of pharmacological and mechanical 
stimulation to help induce fainting during blood pressure and heart rate 
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monitoring in susceptible individuals [6]. However, the recent NICE guidance on 
transient loss of consciousness minimises the importance of tilt table testing 
while missing the nuances of its benefits to clinicians and patients [7]. Below we 
show how tilt table testing continues to be a safe, useful addition to the syncope 
diagnosis and management armamentarium. 
 
Safety 
Tilt-table testing is arguably one of the safest, simplest and least restrictive or 
invasive investigations in the evaluation of syncope.  In 1,969 consecutive tilt-
tests performed in people aged over 60 years, an episode of atrial fibrillation, 
with no cardiovascular or neurological complication, was the only complication 
identified [8].  The most commonly cited case report relating to the safety of tilt-
testing is that of an 80 year old female who developed (and survived) an episode 
of ventricular fibrillation during an isoproterenol tilt-test [9].  She was known to 
have a history of coronary artery disease and a conduction defect on her ECG, 
which today, would preclude her from having isoproterenol.  Indeed, even a 
passive tilt-test would not be recommended in high risk individuals until a 
cardiac cause had been excluded and the history was suggestive of VVS. 
 
Accuracy 
One of the principle arguments against tilt-testing is its sensitivity and 
specificity.  This varies widely, depending on inclusion/exclusion criteria, 
methodology (e.g. tilt angle, duration, provocation method), interpretation of 
result and expertise of the clinician.  Perhaps the most widely used method is 
‘The Italian Protocol’ which consists of a 20-minute passive upright phase, 
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followed by a 15-minute provocation phase (400 mcg sublingual glyceryl 
trinitrate) [10].   It may be a surprise to sceptics of the tilt-test to note that the 
sensitivity (62%) and specificity (92%) of this protocol is high and fares very 
well when compared to other commonly used clinical investigations.  For 
example, the chest X-ray diagnosis of pneumothorax (sensitivity 52%, specificity 
99%) or the ECG in diagnosing an ST elevation myocardial infarction (sensitivity 
56%, specificity 94%) [11, 12].  
 
Diagnosis 
While it is not suggested that all cases of suspected VVS should undergo tilt-table 
testing, it is an extremely useful tool for those in whom the diagnosis is in doubt, 
where there are driving or employment restrictions or for guiding the treatment 
strategy. 
 
The majority of syncopal episodes can be confidently diagnosed as VVS in the 
context of a structurally normal heart, normal surface ECG and an appropriate 
clinical history [2, 6] with no further investigation.  However, in the absence of 
these features, tilt-testing can provide a valuable diagnostic and educational tool.  
Although there are no trials assessing the accuracy of the diagnosis based on 
simple clinical evaluation there are scoring tools based on features from the 
history, examination and ECG findings.  However, with a sensitivity of 87% and 
specificity of 32% these tools provide little support for their use in the diagnosis 
of VVS [13].  
 
Unexplained syncope 
Page 5 of 11 
 
The diagnosis of VVS is often complex; a classic example of this being the older 
person who presents with unheralded syncope, recurrent unexplained falls or 
drop attacks.  Older people with VVS are less likely to report dizziness, 
palpitations and syncope, and less likely to associate the event with change in 
posture, hot environments or prolonged standing [14].  This may be partly 
explained by the differing patterns of hypotension and bradycardia associated 
with fainting in older and younger age groups. Older people with VVS tend to 
have a dysautonomic pattern of progressive blood pressure drop prior to sudden 
collapse with loss of consciousness, compared to the younger patient with the 
classical prodromal symptoms of VVS who collapses with a rapid fall in blood 
pressure and/or heart rate [15]. To add to the complexity, older people are more 
likely to have a history of cardiac disease and an abnormal ECG, but where a 
cardiac cause has been excluded, tilt-testing provides a safe and rapid diagnostic 
method. The combination of these factors makes the diagnosis of VVS more 
challenging in older people and emphasises the value of tilt-testing in complex 
cases. 
 
Epilepsy 
Epilepsy is a life changing diagnosis, with implications for driving, employment, 
life-long medication, stigma and family planning issues.  The history is 
characteristic for many patients with seizure disorders, with prolonged loss of 
consciousness and post-event confusion, muscle aching and lateral tongue biting 
being very suggestive of seizure rather than syncope. [16].  However, 
convulsions can occur in up to 80% of people with a syncopal episode [17] and 
history alone may not be adequate when attempting to distinguish VVS from 
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epilepsy; clinical history has a specificity of only 50% in suspected temporal lobe 
epilepsy [18].  One retrospective study revealed that 27% of cases of epilepsy 
were misdiagnosed when in fact they had VVS [19].  Tilt-testing has much to 
offer in terms of improving the precision of diagnosis, indeed, it has the highest 
diagnostic yield for cases of unexplained seizures in apparent treatment-
resistant epilepsy [19]. 
 
Further benefits 
Driving 
The UK Driver and Vehicle Licencing Agency has strict regulations that often 
result in driving restrictions following syncope.  For example, for a single 
episode of unexplained syncope, a bus or lorry driver would be prevented from 
driving for 3 months after the event, even if the probability of VVS were high.  
The restrictions may be longer in the presence of high-risk features such as an 
abnormal ECG or injury sustained during the episode, but if the cause is 
identified and treated the restrictions are shorter.  In such circumstances 
syncope has huge implications for an individual who may lose their income.  
Timely tilt-testing in this situation is crucial. 
 
Employment 
Rapid diagnosis and initiation of treatment is equally important for those who 
are unable to work in high-risk employment (e.g. at height, with dangerous 
machinery/chemicals), until diagnosis is ascertained and treatment started. 
 
Education 
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For those individuals who have short-lived premonitory symptoms, or those 
who do not recognise the pre-syncopal warning a tilt-test is a valuable tool to 
educate individuals how to recognise presyncope, when to begin abortive 
measures and to demonstrate how effective and simple abortive measures are. 
 
Treatment strategy 
A definitive diagnosis of VVS is required when formulating a management plan.  
Not least to avoid treatment in those inaccurately diagnosed from simple clinical 
evaluation alone.  Decision-making can be complex, for example in those with 
heart or liver failure, and requires certainty of diagnosis before balancing the 
risks/benefits of treatment.  The two most commonly used medications for VVS 
come at a price.  Fludrocortisone requires regular monitoring of electrolytes and 
can cause interstitial oedema; midodrine is prescribed off licence, requires close 
monitoring for supine hypertension and can cause liver failure.  Midodrine 
should not be used without tilt-test confirmation of VVS. 
 
Furthermore, recent work highlights the benefits of permanent pacing in 
patients with tilt-positive vasovagal syncope and prolonged asystole recorded 
during spontaneous events. Without the tilt-test such patients would be denied 
definitive management [20]. 
 
Conclusion 
Tilt-testing is safe, accurate and non-invasive.  It increases diagnostic rates in 
unexplained syncope and can help reduce mis-diagnosis in some patients with 
apparent treatment-resistant epilepsy It should be used early when there are 
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driving or employment restrictions but also in older people with unheralded 
syncope, unexplained falls and drop attacks where a cardiac or alternative cause 
has been excluded.  The test can be of substantial benefit in syncope 
management, highlighting previously unnoticed premonitory symptoms to help 
patients recognise and hence abort an incipient faint. Used wisely it is a 
powerful, cheap and safe diagnostic and management tool in patients with these 
distressing symptoms.  
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